AAAAAA
Results:
1-16
|
Results: 16
Authors:
Bornstein, NM
Citation: Nm. Bornstein, Antiplatelet drugs: How to select them and possibilities of combined treatment, CEREB DIS, 11, 2001, pp. 96-99
Authors:
Fusman, R
Rotstein, R
Zeltser, D
Prochorov, V
Shapira, I
Bornstein, NM
Keren, G
Roth, A
Miller, HI
Avitzour, D
Arber, N
Berliner, S
Citation: R. Fusman et al., The state of leukocyte adhesiveness/aggregation in the peripheral blood ofpatients with type 2 diabetes and ischemic vascular disease, ACT DIABETO, 38(1), 2001, pp. 43-49
Authors:
Koton, S
Bornstein, NM
Green, MS
Citation: S. Koton et al., Population group differences in trends in stroke mortality in Israel, STROKE, 32(9), 2001, pp. 1984-1988
Authors:
Bornstein, NM
Aronovich, B
Korczyn, AD
Shavit, S
Michaelson, DM
Chapman, J
Citation: Nm. Bornstein et al., Antibodies to brain antigens following stroke, NEUROLOGY, 56(4), 2001, pp. 529-530
Authors:
Zeltser, D
Bornstein, NM
Rotstein, R
Shapira, I
Berliner, AS
Citation: D. Zeltser et al., The erythrocyte adhesiveness/aggregation test in the peripheral blood of patients with ischemic brain events, ACT NEUR SC, 103(5), 2001, pp. 316-319
Authors:
Rotstein, R
Zeltser, D
Fusman, R
Shapira, I
Urbach, J
Bornstein, NM
Roth, A
Keren, G
Avitzour, D
Arber, N
Berliner, S
Citation: R. Rotstein et al., The inflammation meter (INFLAMET): A new diagnostic approach to reveal thepresence of an inflammatory response and assess its intensity, ISR MED ASS, 2(6), 2000, pp. 476-477
Authors:
Gur, AY
Bornstein, NM
Citation: Ay. Gur et Nm. Bornstein, Are there any unique epidemiological and vascular risk factors for ischaemic strokes that occur in the morning hours?, EUR J NEUR, 7(2), 2000, pp. 179-181
Authors:
Wein, TH
Bornstein, NM
Citation: Th. Wein et Nm. Bornstein, Stroke prevention - Cardiac and carotid-related stroke, NEUROL CLIN, 18(2), 2000, pp. 321
Authors:
Kupferminc, MJ
Yair, D
Bornstein, NM
Lessing, JB
Elder, A
Citation: Mj. Kupferminc et al., Transient focal neurological deficits during pregnancy in carriers of inherited thrombophilia, STROKE, 31(4), 2000, pp. 892-895
Authors:
Bova, I
Sylantiev, C
Bornstein, NM
Chapman, J
Korczyn, AD
Citation: I. Bova et al., Frequent polymorphism of the human methylenetetrahydrofolate reductase - Response, STROKE, 31(4), 2000, pp. 990-990
Authors:
Bova, I
Sylantiev, C
Bornstein, NM
Chapman, J
Korczyn, AD
Citation: I. Bova et al., The A677V MTHFR allele is not associated with carotid atherosclerosis in octogenarians - Response, STROKE, 31(4), 2000, pp. 991-991
Authors:
Berliner, S
Rogowski, O
Rotstein, R
Fusman, R
Shapira, I
Bornstein, NM
Prochorov, V
Roth, A
Keren, G
Eldor, A
Zeltser, D
Citation: S. Berliner et al., Activated polymorphonuclear leukocytes and monocytes in the peripheral blood of patients with ischemic heart and brain conditions correspond to the presence of multiple risk factors for atherothrombosis, CARDIOLOGY, 94(1), 2000, pp. 19-25
Authors:
Bornstein, NM
Citation: Nm. Bornstein, Antiaggregants, old and new: which ones? In what cases? Mode of action, PREVENTION OF ISCHEMIC STROKE, 2000, pp. 113-121
Authors:
Bornstein, NM
Gur, AY
Fainshtein, P
Korczyn, AD
Citation: Nm. Bornstein et al., Stroke during sleep: Epidemiological and clinical features, CEREB DIS, 9(6), 1999, pp. 320-322
Authors:
Bova, I
Chapman, J
Sylantiev, C
Korczyn, AD
Bornstein, NM
Citation: I. Bova et al., The A677V methylenetetrahydrofolate reductase gene polymorphism and carotid atherosclerosis, STROKE, 30(10), 1999, pp. 2180-2182
Authors:
Easton, JD
Diener, HC
Bornstein, NM
Einhaupl, K
Gent, M
Kaste, M
Sacco, RL
Tijssen, JGP
van Gijn, J
Citation: Jd. Easton et al., Antiplatelet therapy: Views from the experts, NEUROLOGY, 53(7), 1999, pp. S32-S37
Risultati:
1-16
|